- Record: found
- Abstract: not found
- Article: not found
Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery
Rajendra H. Mehta ,
Jeffrey D. Leimberger ,
Sean van Diepen ,
James Meza ,
Alice Wang ,
Rachael Jankowich ,
Robert W. Harrison ,
Douglas Hay ,
Stephen Fremes ,
Andra Duncan ,
Edward G. Soltesz ,
John Luber ,
Soon Park ,
Michael Argenziano ,
Edward Murphy ,
Randy Marcel ,
Dimitri Kalavrouziotis ,
Dave Nagpal ,
John Bozinovski ,
Wolfgang Toller ,
Matthias Heringlake ,
Shaun G. Goodman ,
Jerrold H. Levy ,
Robert A. Harrington ,
Kevin J. Anstrom ,
John H. Alexander
May 25 2017
May 25 2017
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Levosimendan is an inotropic agent that has been shown in small studies to prevent
or treat the low cardiac output syndrome after cardiac surgery.
Related collections
Most cited references22
- Record: found
- Abstract: found
- Article: not found
Heart Disease and Stroke Statistics—2016 Update
Dariush Mozaffarian, Emelia Benjamin, Alan S Go … (2016)
- Record: found
- Abstract: not found
- Article: not found
2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
Rick A. Nishimura, Catherine M Otto, Robert Bonow … (2014)
- Record: found
- Abstract: not found
- Article: not found
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
L Hillis, Peter K. Smith, Jeffrey Anderson … (2011)